CSIMarket Company Name, Ticker, Competitors, else..
 

Nkarta Inc   (NASDAQ: NKTX)

Nkarta Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

NKTX Sales vs. its Competitors Q2 2026


Comparing the current results to its competitors, Nkarta Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 5.7 %, recorded in the same quarter.

• List of NKTX Competitors





Revenue Growth Comparisons




Net Income Comparison

Nkarta Inc , slower than the average decrease reported by the company's competitors of -59.63 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -59.63 %

<<  NKTX Stock Performance Comparisons





*Market share is calculated based on total revenue.





Publicly Traded Peers of Nkarta Inc




Indaptus Therapeutics Inc
Share Performance



-13.97%
30 Days
Indaptus Therapeutics Inc
Profile

Indaptus Therapeutics Inc's business model focuses on developing and commercializing innovative therapies in the healthcare industry.

More about Indaptus Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 135.874 mill. $ - mill. $ -15.424 mill.


Neurogene Inc
Share Performance



+11.48%
30 Days
Neurogene Inc
Profile

The company develops genetic medicines targeting rare neurological diseases and is currently in clinical stages.

More about Neurogene Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 855.648 mill. $ - mill. $ -98.638 mill.


Nkgen Biotech Inc
Share Performance



0.00%
Over The Past 5 Days
Nkgen Biotech Inc
Profile

Nkgen Biotech Inc is a biotechnology company that focuses on developing and commercializing innovative cell therapies for the treatment of various diseases. Their business model involves conducting extensive research to identify and isolate specific cells capable of addressing medical conditions, followed by developing manufacturing processes to produce these cells in large quantities. They aim to partner with healthcare providers and pharmaceutical companies to ensure the effective distribution and delivery of their therapies to patients in need.

More about Nkgen Biotech Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.513 mill. $ - mill. $ 17.049 mill.


Novavax inc
Share Performance



+34.73%
30 Days
Novavax inc
Profile

Novavax Inc is a biotechnology company focused on the discovery, development, and commercialization of novel vaccines. They aim to leverage their proprietary recombinant nanoparticle vaccine technology platform to address a wide range of infectious diseases. By collaborating with partners and conducting clinical trials, Novavax works towards bringing innovative vaccines to the global market.

More about Novavax inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,685.008 mill. $ 596.338 mill. $ -87.835 mill.


Novartis Ag
Share Performance



+17.27%
This Year
Novartis Ag
Profile

Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.

More about Novartis Ag's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 317,609.300 mill. $ 70,725.000 mill. $ 17,991.000 mill.

57 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Nkarta Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nkarta Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.